• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493941816220
Medical Device Problem Codes Break (1069); Material Deformation (2976)
Health Effect - Clinical Codes No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/26/2020
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that shaft break occurred.The 80-90% stenosed target lesion was located in the mildly tortuous and moderately calcified left anterior descending artery.A 2.25 x 16mm synergy xd drug-eluting stent was advanced for treatment.However, while trying to cross the lesion, the shaft broke outside the patient 20-25cm distal from the hub.The device was completely pulled out and another device was used to complete the procedure.No patient complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: synergy xd mr us 2.25 x 16mm stent delivery system was returned for analysis with a haemostatic valve attached.Examination of the crimped stent via scope found no issues with the stent.There were no signs of damage, stretching or lifting of the stent struts.The stent showed no signs of movement and was set between the proximal and distal marker bands.The crimped stent outer diameter was measured and the result is within max crimped stent profile measurement.The balloon cones were reviewed via scope, and no issues were noted.The balloon wings were tightly wrapped and evenly folded.The balloon had not been subjected to positive pressure.A visual and tactile examination of the hypotube found multiple kinks and a break 19.7cm distal to the distal end of the strain relief.Examination of the tip via scope found no damage to the tip.The shaft polymer extrusion including the distal and mid-shaft sections were examined via scope and a tactile examination was performed.No issues were noted.No other issues were identified during the product analysis.
 
Event or Problem Description
It was reported that shaft break occurred.The 80-90% stenosed target lesion was located in the mildly tortuous and moderately calcified left anterior descending artery.A 2.25 x 16mm synergy xd drug-eluting stent was advanced for treatment.However, while trying to cross the lesion, the shaft broke outside the patient 20-25cm distal from the hub.The device was completely pulled out and another device was used to complete the procedure.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11154840
Report Number2134265-2020-18799
Device Sequence Number3383467
Product Code NIQ
UDI-Device Identifier08714729980728
UDI-Public08714729980728
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 02/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/09/2022
Device Model NumberH7493941816220
Device Lot Number0026047681
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/19/2021
Initial Date Received by Manufacturer 12/30/2020
Supplement Date Received by Manufacturer02/02/2021
Initial Report FDA Received Date01/12/2021
Supplement Report FDA Received Date02/17/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-